• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

RFA, embolization protocol safely treats large fibroids

Article

Reducing fibroid volume with radiofrequency ablation and then embolizing the fibroids is safe and feasible, according to a study presented at the 2005 RSNA meeting.

Reducing fibroid volume with radiofrequency ablation and then embolizing the fibroids is safe and feasible, according to a study presented at the 2005 RSNA meeting.

Dr. Hyun Kim and Jason Tsai of Johns Hopkins treated 22 symptomatic patients with large subserosal fibroids with RFA and uterine fibroid embolization. They used an RF probe up to 5 cm.

They achieved RFA target ablation size and temperature in 95.5% (21/22) of patients. A mean fibroid volume reduction of 49% was achieved (549 cc pretreatment versus 280.8 cc post-treatment). After one day, an MR scan in 10 patients showed no extra-uterine organ damage, as well as no infection, hemorrhagic complication, or fluid in pelvis or peritoneum. One patient developed delayed minimal drainage via RFA probe skin access, which resolved spontaneously over two days.

Follow-up at one year has revealed no significant morbidity, positive symptom severity scores, and few complications.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.